Do I Need Progesterone With My Estrogen on HRT?

If you've recently started HRT, or you're researching it before your first appointment, you've probably encountered some version of this question: do I actually need to take progesterone, or can I just take estrogen?

The short answer is: it depends on whether you have a uterus. But the longer answer, the one that helps you understand your prescription, ask the right questions, and feel confident about your treatment, is considerably more useful.

This guide covers the clinical reasoning behind combined vs. estrogen-only HRT, who the exceptions are, what your progestogen options actually look like, and how to know if your current regimen is working the way it should.

The Core Principle: Protecting the Endometrium

Here's the fundamental clinical reason progesterone is prescribed alongside estrogen: estrogen stimulates the lining of the uterus (the endometrium) to thicken. In a normal menstrual cycle, fluctuations in progesterone are what causes that lining to shed each month. Without it, estrogen-driven thickening can progress to endometrial hyperplasia, an abnormal overgrowth of the uterine lining, and over time, if untreated, to endometrial cancer.

This is not a theoretical risk. Research has established clearly that unopposed estrogen, estrogen taken without a progestogen, significantly raises the risk of endometrial cancer in women with an intact uterus. Progestogen is prescribed specifically to prevent this. It is the endometrial protection component of combined HRT.

This is why the answer to "do I need progesterone?" is almost entirely determined by one anatomical fact: do you still have your uterus?

If You Have an Intact Uterus: Yes, You Need Progestogen

If your uterus is intact, current guidelines from The Menopause Society, the British Menopause Society (BMS), and major clinical bodies worldwide are consistent: estrogen must be paired with a progestogen. How it's prescribed depends on where you are in your transition.

Continuous combined HRT is the most common recipe.  You take both estrogen and progestogen every day, with no break, aiming to become bleed-free. This is the standard long-term combined regimen for postmenopausal women.

Sequential (cyclical) HRT is another option used by many women.  You take estrogen continuously and add progestogen for 12–14 days per month, this usually produces a monthly withdrawal bleed. 

The Mirena IUS is a third option some women use. A levonorgestrel-releasing intrauterine device provides local endometrial protection while you take systemic estrogen (patch, gel, or spray) separately. This is an increasingly popular combination, particularly for women who find oral progestogens difficult to tolerate.

If You've Had a Hysterectomy: Estrogen-Only Is Usually Appropriate

If you've had a total hysterectomy, removal of the uterus, there is no endometrial lining to protect, which means the primary reason for adding progestogen no longer applies. Estrogen-only therapy is the standard recommendation for women without a uterus.

This matters clinically because the evidence on estrogen-only HRT is actually favorable on several fronts. A 2024 updated analysis published in Menopause: The Journal of the Menopause Society, looking at 40 different hormonal therapy regimens in women 65 and older, found that estrogen-only HRT was associated with a 19% reduction in overall mortality, as well as reduced risk across a range of conditions including breast cancer, lung cancer, colorectal cancer, congestive heart failure, atrial fibrillation, and dementia. The risk profile for estrogen-only therapy is generally considered more favorable than estrogen-plus-progestogen combined therapy.

In short: if you don't have a uterus, adding progestogen introduces additional hormone exposure and potential side effects without a protective benefit for most women. The standard guidance is estrogen alone.

The exception: endometriosis history

If you've had a hysterectomy but have a documented history of endometriosis, particularly if there may be residual endometrial tissue remaining, estrogen-only therapy may not be appropriate. Endometriosis is an estrogen-dependent condition, and unopposed estrogen has been associated with a risk of reactivation or, rarely, malignant transformation of residual deposits. In this situation, combined estrogen and progestogen therapy is often recommended even post-hysterectomy. This is a clinical nuance your prescribing doctor should address directly, so make sure your endometriosis history is part of the conversation.

Subtotal hysterectomy

If you had a subtotal hysterectomy, meaning the cervix was preserved but the uterine body was removed, there may still be a small amount of endometrial tissue present. Some clinicians will recommend combined therapy in this scenario. Confirm with your doctor what was removed and whether endometrial protection is still indicated.

Your Progestogen Options: Not All Are the Same

For women who do need progestogen, this matters: there is a meaningful clinical difference between natural micronized progesterone and synthetic progestins, and the distinction is worth understanding.

Micronized progesterone (brand name Utrogestan; available as generic 100mg and 200mg capsules) is bioidentical, it is chemically identical to the progesterone your body produces. It provides effective endometrial protection and has a more favorable safety profile compared to many synthetic alternatives, particularly regarding cardiovascular risk and breast cancer risk. It also has a mild sedative effect via its GABA-activating metabolite allopregnanolone, which is why it's typically taken at bedtime, and why many women find it also improves their sleep. On the low progesterone side of the spectrum, some women are sensitive to even micronized progesterone and experience mood changes, bloating, or fatigue.

Synthetic progestins, including medroxyprogesterone acetate (MPA), levonorgestrel, and others, are structurally modified molecules developed to enhance oral bioavailability and progestogenic potency. They effectively prevent endometrial hyperplasia, but they interact with androgen, glucocorticoid, and mineralocorticoid receptors to varying degrees, which produces different side effect profiles across women. Some synthetic progestins, particularly older-generation options, have been associated with a less favorable breast cancer and cardiovascular risk profile than micronized progesterone. 

The Mirena IUD delivers levonorgestrel locally to the uterus, which means very little systemic absorption, this makes it a good option for women who have side effects from oral or transdermal progestogens.

Bazedoxifene:  If you're experiencing side effects from your current progestogen, mood disruption, bloating, fatigue, breast tenderness, it's worth discussing whether switching the type or route of administration might help. Women who can't tolerate any progestogen have an alternative: estrogen combined with bazedoxifene (a selective estrogen receptor modulator), which provides endometrial protection without progestogen. This combination is FDA-approved and available under the brand name Duavee.

Dosing: Getting the Balance Right With Your Estrogen

One thing that's shifted in clinical guidance recently is the recognition that progestogen dose should be proportionate to estrogen dose. This seems intuitive, but it wasn't always reflected in prescribing practice.

In April 2024, the British Menopause Society updated its guidance, developed in conjunction with the Royal College of Obstetricians and Gynaecologists and other major bodies, specifically in response to a rise in unscheduled bleeding and endometrial concerns among women on higher-dose estrogen. The updated recommendation: if you're on high-dose estrogen, your progestogen dose should be increased accordingly to ensure adequate endometrial protection. 

If you've recently increased your estrogen dose, it's worth checking with your prescriber whether your progestogen dose has been adjusted to match. This is exactly the kind of optimization question that could get missed in a 15-minute appointment.

How to Know If Your Progestogen Component Is Working

For endometrial protection, the most important clinical signal to watch for is unscheduled bleeding. If you're on sequential/cyclic HRT, you should expect a withdrawal bleed during or after your progestogen phase. Bleeding outside that window, or heavier, longer, or more frequent bleeding than expected, warrants a conversation with your clinician and potentially an endometrial assessment.

If you're on continuous combined HRT, the goal is to be bleed-free. Irregular spotting in the first 3–6 months of switching to continuous therapy is common and usually resolves. Bleeding that continues beyond 6 months, or returns after a bleed-free period, should always be investigated.

For symptom relief, the picture is different. Most women find progestogen contributes positively, particularly the sleep benefits of micronized progesterone. Others find it counteracts the mood improvement they get from estrogen. Tracking your symptoms alongside your hormone levels across your cycle, including which days you're taking progestogen and which you're not, is one of the clearest ways to identify whether progestogen is helping, neutral, or causing side effects that need addressing.

Frequently Asked Questions

I had a hysterectomy but still have my ovaries. Do I need progesterone?

No, if your uterus has been removed, the reason for adding progestogen (protecting the endometrial lining) is gone. The presence or absence of your ovaries affects whether you need hormone therapy at all (ovary removal triggers surgical menopause; intact ovaries continue producing hormones), but it doesn't change the principle that estrogen-only therapy is appropriate once the uterus is absent. The exception, as above, is a history of endometriosis.

My doctor prescribed estrogen-only HRT but I still have my uterus. Is that right?

In most cases, no, estrogen-only therapy in women with an intact uterus is not recommended due to endometrial cancer risk. If you've been prescribed estrogen alone and are unsure whether you were prescribed progestogen separately or whether it was an oversight, clarify with your prescriber before continuing. It's also worth asking specifically: "Do I need a progestogen with this prescription?"

Can I take progesterone on its own without estrogen?

Yes, progesterone-only therapy is used in some contexts, particularly for women who can't tolerate estrogen or have contraindications to it. Oral micronized progesterone at 300mg nightly has shown some efficacy for vasomotor symptoms and sleep in some studies. However, progesterone-only is not the standard first-line approach for perimenopausal or menopausal symptom management. Discuss with a menopause specialist whether it's appropriate for your situation.

I'm getting side effects from progestogen, mood changes, bloating, fatigue. What should I do?

Don't stop your progestogen without medical advice if you have a uterus, as this removes your endometrial protection. Instead, discuss with your prescriber: switching from a synthetic progestogen to micronized progesterone (if you're not already on it), switching to a Mirena IUD to avoid the systemic affects, or consider the estrogen-plus-bazedoxifene combination. Side effects from progestogen are one of the most common reasons women discontinue HRT unnecessarily, there are alternatives worth trying before giving up. You can also learn more about tracking whether your HRT dose is optimized overall.

What's the difference between progesterone and progestogen?

Progesterone refers specifically to the natural hormone, bioidentical, chemically identical to what your body produces.  Prometrium is a progesterone.  Progestogen is the broader term that includes both natural progesterone and synthetic progestins. All progestogens protect the endometrium; they differ in how they interact with other hormone receptors in the body, which affects their side effect and safety profiles. 

Does progestogen affect breast cancer risk?

This is one of the most frequently asked questions about combined HRT and the evidence is nuanced. The type of progestogen matters significantly. Studies suggest that micronized progesterone (bioidentical) carries a more favorable breast cancer risk profile compared to some synthetic progestins, particularly older-generation ones. The absolute risk figures are small and depend heavily on duration of use, individual health history, and the type of estrogen and progestogen used. The FDA's removal of the blanket black box warning from HRT labeling in November 2025 reflected a shift toward more individualized, evidence-based risk communication. This is a conversation to have directly with your prescriber based on your personal and family history.